Poolbeg Pharma PLC
POLB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £16,716 | £35,320 | £65 | £45 |
| - Cash | £9,961 | £7,824 | £10,061 | £12,171 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £6,755 | £27,496 | -£9,996 | -£12,126 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | -£26 | -£101 | -£13 | -£13 |
| % Margin | – | – | – | – |
| EBITDA | -£2,207 | -£3,481 | -£2,270 | -£2,681 |
| % Margin | – | – | – | – |
| Net Income | -£2,178 | -£3,532 | -£2,258 | -£2,120 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.007 | -4.52 | -4.28 |
| % Growth | 39.4% | 99.8% | -5.6% | – |
| Operating Cash Flow | -£2,346 | -£2,384 | -£2 | -£1,836 |
| Capital Expenditures | £0 | £0 | £0 | -£113 |
| Free Cash Flow | -£2,346 | -£2,384 | -£2 | -£1,949 |